Duloxetine improves chronic orofacial pain and comorbid depressive symptoms in association with reduction of serotonin transporter protein through upregulation of ubiquitinated serotonin transporter protein

Post time 2024-5-2 12:02:35

journal：Pain

Authors：Mariko Nakamura; Akira Yoshimi; Tatsuya Tokura; Hiroyuki Kimura; Shinichi Kishi; Tomoya Miyauchi; Kunihiro Iwamoto; Mikiko Ito; Aiji Sato-Boku; Akihiro Mouri; Toshitaka Nabeshima; Norio Ozaki; Yukihiro Noda

Published date：2024-5-

DOI：10.1097/j.pain.0000000000003124

PDF link：https://journals.lww.com/10.1097/j.pain.0000000000003124

Article link：http://dx.doi.org/10.1097/j.pain.0000000000003124

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 2024-5-2 12:02:36

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Ovid] Duloxetine improves chronic orofacial pain and comorbid depressive symptoms in association with reduction of serotonin transporter protein through upregulation of ubiquitinated serotonin transporter protein

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Ovid] Duloxetine improves chronic orofacial pain and comorbid depressive symptoms in association with reduction of serotonin transporter protein through upregulation of ubiquitinated serotonin transporter protein Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Ovid] Duloxetine improves chronic orofacial pain and comorbid depressive symptoms in association with reduction of serotonin transporter protein through upregulation of ubiquitinated serotonin transporter protein